Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin versus erythropoietin in dialysis patients with anemia
ISRCTN96020335Phase 4Completed
- Sponsor
- National Institutes of Health
- Start
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes, Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in anemia of renal disease comparing Darbepoetin alfa with Erythropoietin (2 arms). Primary endpoint: Hemoglobin levels at week 22. Started Jul 2016; status: completed.
02
Drugs
darbepoetin alfaerythropoietin
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on ISRCTN96020335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96020335.